CD14++CD16− monocytes have high expression of the activation marker CD163 and were found to be closely associated with plasma levels of systemic pro-inflammatory markers CRP, IL-6, TNF-α, and soluble tissue factor (CD142) prior to ART initiation and during TB-IRIS [134]. This evidence concerns the gene IL6 and tuberculosis.